Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva suffers trial loss in New York's landmark opioid case | FiercePharma
Teva shares tumble as company faces price-fixing lawsuit - The Jerusalem Post
J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | FiercePharma
Generic Drug Lawsuit Could Mean Big Fines for Teva, Mylan: UBS
Teva boss hits out at opioid lawsuits | Financial Times
Teva's Shady Legal Past Still Weighs on the Debt-Laden Pharma Company | Ctech
Teva said to 'walk away' from settlement talks in US price-fixing lawsuit | The Times of Israel
Teva and 3 Drug Distributors Settle Opioid Lawsuits in Ohio Ahead of Trial | BioSpace
Teva worked with other drug firms to inflate prices, lawsuit claims - Axios
J&J, Teva and Other Opioid Drugmakers Face $50 Billion Lawsuit in California | BioSpace
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva's generic label not skinny enough to protect from $234M damages to GSK - MedCity News
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Teva Pharmaceuticals Retirement Savings Plan Class Action Lawsuit
Teva wins opioids case in California court - Globes
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Teva found liable for fueling opioid addiction in New York
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Report: Teva Settles Investor Lawsuit for $420M - Hamodia.com
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
